SG11201407314XA - Compositions and methods for the treatment of diabetes - Google Patents

Compositions and methods for the treatment of diabetes

Info

Publication number
SG11201407314XA
SG11201407314XA SG11201407314XA SG11201407314XA SG11201407314XA SG 11201407314X A SG11201407314X A SG 11201407314XA SG 11201407314X A SG11201407314X A SG 11201407314XA SG 11201407314X A SG11201407314X A SG 11201407314XA SG 11201407314X A SG11201407314X A SG 11201407314XA
Authority
SG
Singapore
Prior art keywords
international
diabetes
compositions
treatment
methods
Prior art date
Application number
SG11201407314XA
Other languages
English (en)
Inventor
Mahesh Kandula
Original Assignee
Cellix Bio Private Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellix Bio Private Ltd filed Critical Cellix Bio Private Ltd
Publication of SG11201407314XA publication Critical patent/SG11201407314XA/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
SG11201407314XA 2012-05-08 2013-01-29 Compositions and methods for the treatment of diabetes SG11201407314XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1788CH2012 2012-05-08
PCT/IB2013/050744 WO2013167987A1 (en) 2012-05-08 2013-01-29 Compositions and methods for the treatment of diabetes

Publications (1)

Publication Number Publication Date
SG11201407314XA true SG11201407314XA (en) 2014-12-30

Family

ID=54193689

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201407314XA SG11201407314XA (en) 2012-05-08 2013-01-29 Compositions and methods for the treatment of diabetes

Country Status (8)

Country Link
EP (1) EP2847161A4 (ja)
JP (1) JP2015521174A (ja)
CN (1) CN104364230A (ja)
AU (1) AU2013257708A1 (ja)
CA (1) CA2873084A1 (ja)
SG (1) SG11201407314XA (ja)
WO (1) WO2013167987A1 (ja)
ZA (1) ZA201408065B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013257745A1 (en) * 2012-05-07 2014-11-27 Cellixbio Private Limited Prodrugs of anti-platelet agents
AU2013285126A1 (en) * 2012-07-03 2014-11-27 Cellixbio Private Limited Compositions and methods for the treatment of moderate to severe pain
JPWO2022065133A1 (ja) * 2020-09-25 2022-03-31

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2288997T3 (es) * 2000-10-24 2008-02-01 Ajinomoto Co., Inc. Procedimiento para producir cristales de nateglinida de tipo b.
JP4615866B2 (ja) * 2002-04-15 2011-01-19 ノバルティス アーゲー Ｎ−（トランス−４−イソプロピルシクロヘキシルカルボニル）−ｄ−フェニルアラニンの結晶形
US9085527B2 (en) * 2008-07-08 2015-07-21 Catabasis Pharmaceuticals, Inc. Fatty acid acylated salicylates and their uses
US8946451B2 (en) * 2009-10-05 2015-02-03 Catabasis Pharmaceuticals, Inc. Lipoic acid acylated salicylate derivatives and their uses

Also Published As

Publication number Publication date
ZA201408065B (en) 2016-04-28
CA2873084A1 (en) 2013-11-14
WO2013167987A1 (en) 2013-11-14
EP2847161A1 (en) 2015-03-18
AU2013257708A1 (en) 2014-12-04
CN104364230A (zh) 2015-02-18
JP2015521174A (ja) 2015-07-27
EP2847161A4 (en) 2015-12-23

Similar Documents

Publication Publication Date Title
SG11201407411SA (en) Compositions and methods for the treatment of metabolic syndrome
SG11201407326XA (en) Compositions and methods for treatment of mucositis
SG11201408094YA (en) Neprilysin inhibitors
SG11201408095XA (en) Fibroblast growth factor 21 proteins
SG11201407533SA (en) Antiviral compounds
SG11201805838UA (en) Macrocyclic mcl1 inhibitors for treating cancer
SG11201408539UA (en) Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof
SG11201407037UA (en) Catechol o-methyltransferase activity inhibiting compounds
SG11201408261UA (en) Syringe
SG11201407303SA (en) Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders
SG11201407580YA (en) Composition comprising two antibodies engineered to have reduced and increased effector function
SG11201407115XA (en) Carboxylic acid compounds
SG11201407317SA (en) Compositions and methods for suppression of carbonic anhydrase activity
SG11201407184PA (en) Process for preparation of optically pure and optionally substituted 2- (1 -hydroxy- alkyl) - chromen - 4 - one derivatives and their use in preparing pharmaceuticals
SG11201408750VA (en) NOVEL FUSED PYRIDINE DERIVATIVES USEFUL AS c-MET TYROSINE KINASE INHIBITORS
SG11201407534PA (en) New diazaspirocycloalkane and azaspirocycloalkane
SG11201407596TA (en) Conjugation reagents
SG11201408629QA (en) Dimethyl-benzoic acid compounds
SG11201408332TA (en) Polyisobutylene composition having internal vinylidene and process for preparing the polyisobutylene polymer composition
SG11201407319YA (en) Compositions and methods for treatment of inflammatory bowel disease
SG11201909376TA (en) Crystalline forms of a jak inhibitor compound
SG11201408685WA (en) Antibacterial microelement chelates and the use thereof in animal feeds
SG11201407934UA (en) Camsylate salt
SG11201408641UA (en) Phenoxyethyl piperidine compounds
SG11201407323WA (en) Compositions and methods for the treatment of local pain